From discovery through commercialization, all of us at Ardelyx ® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first ...May 18, 2023 · Q1 net loss was $26.8 million, but Ardelyx raised $51.9 million through sales of their common stock at an average price of about $3.35, leaving $130.4 million in total cash and investments as of ...Choice Hotels are squarely in the mid- and lower-tier group of hotel chains. But look closer to find hidden gems. Let's take a Choice Privileges deep dive! Increased Offer! Hilton ...Mar 2, 2023 · Ardelyx (ARDX) delivered earnings and revenue surprises of 500% and 59.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?We would like to show you a description here but the site won’t allow us.Ardelyx Inc. shares soared more than 60% in after-hours trading Wednesday, after the company reported positive results for a study of a proposed drug. Ardelyx said a second Phase 3 study of ...Tucked into the North Georgia Mountains, if you're wondering what is there to do in Blairsville, Georgia - GET OUTSIDE! Share Last Updated on April 10, 2023 Tucked into the North G...Ardelyx stock has received a consensus rating of buy. The average rating score is and is based on 19 buy ratings, 3 hold ratings, and 0 sell ratings. What was the 52-week low for Ardelyx stock?See Ardelyx, Inc. (ARDX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Get the latest Ardelyx Inc (ARDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Aug 2, 2023 · Ardelyx (ARDX) delivered earnings and revenue surprises of 33.33% and 40.61%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?5 days ago · Ardelyx Inc. shares soared more than 60% in after-hours trading Wednesday, after the company reported positive results for a study of a proposed drug. Ardelyx said a second Phase 3 study of ...Apr. 05. MT. Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy. Mar. 25. CI. Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing. Mar. 22. MT. Ardelyx, Inc. announced that it has received $50 million in funding.ARDX Strong upgrade from a top financial firm ARDX Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the US and internationally. On 3/2/2022 Jefferies Financial Group Upgraded ARDX from Hold to Buy raising the price target from $1.00 to $.Discussing mental health topics with your kid can be hard. Parent Central is here to make it easier — with helpful tips for parents and a read-aloud section for kids. If you're uns...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor for adult patients with CKD on dialysis with hyperphosphatemia. The company will host a conference call on December 29, 2022, at 8:00 AM ET. To participate in the conference call, please call (866) 374-5140 (toll-free) or (404) 400-0571 (toll) and …Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig. ARDELYX AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Ardelyx Inc | A116X0 | ARDX | US0396971071.Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.395 subscribers in the ARDELYX community. The selective sodium hydrogen exchanger 3 (NHE3) inhibitor Tenapanor is being developed by Ardelyx Inc for…Nov 18, 2022 · Shares of Ardelyx (ARDX Quick Quote ARDX - Free Report) were up 41% on Nov 17 after management announced thatan FDA Advisory Committee recommended approving the company’s new drug application ...WALTHAM, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...ARDX. Net Product Sales Revenue: IBSRELA generated $80.1 million in 2023, with Q4 showing a 26% increase over Q3. 2024 Revenue Forecast: Ardelyx projects IBSRELA sales to reach between $140.0 to ...All debt owed by the company, including both long-term and short-term debt. This does not include accounts payable and similar liabilities, but may include leases depending on the analysis. $34 ...That whooshing sound you hear is the scads of euro notes being withdrawn from Greek banks. That whooshing sound you hear is the scads of euro notes being withdrawn from Greek banks...Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover ...Cablevision B will present their latest quarterly figures on November 10.Analysts are expecting earnings per share of ARS 17.52.Go here to watch C... Cablevision B will report earn...Ardelyx (NASDAQ:ARDX): A Commercial-Stage Biopharma Stock with Growth Potential. 9d ago. ARDX. Press Releases. Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference. 1d ago. ARDX. The Fly. Ardelyx presents additional data at 2024 DDW conference on IBSRELA.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Ardelyx is a well-funded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. This presentation is intended for investor purposes only and is not intended for promotional purposes.Ardelyx, Inc. Reports Employment Inducement Grants. WALTHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on May 6, 2024, the compensation committee of the company’s board of ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comTrack Intelligent Bio Solutions Inc (INBS) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSeptember 8, 2023 - 8:00 am. WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will present at the H.C ...Greater Boston 400 Fifth Avenue, Suite 210 Waltham, MA 02451 Bay Area 34175 Ardenwood Boulevard Fremont, CA 94555Ardelyx, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and welcome to the Ardelyx […] Insider Monkey •...Provide competitive compensation, a full range of benefits and amazing perks. If you’re interested in becoming part of the Ardelyx® family, please submit your resume for any of our Open Positions. Lots of biotech companies say they are unique. We believe we truly are. With an ethos of constant learning, belief in each other.According to Seeking Alpha data, Ardelyx's market cap of $864.92M shows decent market confidence, especially with its robust revenue growth forecasts: 2023 at $100.6M, and 2024 at $175.84M ...Earnings Estimate Revisions for Ardelyx. For the fiscal year ending December 2023, this biotechnology company is expected to earn -$0.27 per share, which is a change of 35.7% from the year-ago ...Ardelyx has a 1-year low of $3.16 and a 1-year high of $10.13. The company has a quick ratio of 4.36, a current ratio of 4.53 and a debt-to-equity ratio of 0.66. Ardelyx ( NASDAQ:ARDX – Get Free ...Discover real-time Ardelyx, Inc. Common Stock (ARDX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for …Ardelyx News: This is the News-site for the company Ardelyx on Markets Insider Indices Commodities Currencies StocksArdelyx's earnings release in May of 2023 will be important to see if sales growth for ibsrela continues. The global irritable bowel syndrome market is estimated to reach $2.01 billion by 2026.127.89%. BEAT. Q2'23. -$0.12. -$0.08. 30.61%. BEAT. Checkout Ardelyx Inc (ARDX) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether ARDX beat the street expectations or not?Track Seres Therapeutics Inc (MCRB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack HeartBeam Inc (BEAT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsArdelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations.Track ABVC BioPharma Inc (ABVC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors3 days ago · Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH. 19 days ago - GlobeNewsWire.Ardelyx Inc • Biotechnology Wed 22 May, close Current 1 day ago 2 days ago 3 days ago 4 days ago 5 days ago 6 days ago 7 days ago 8 days ago 9 days ago 10 days ago 11 days ago 12 days ago 13 days ago 14 days ago 15 days ago 16 days ago 17 days ago 18 days ago 19 days ago 20 days ago 21 days ago 22 days ago 23 days ago 24 days ago 25 days agoTipRanks | Stock Market Research, News and Analyst Forecasts ...Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update. Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for …Shares of Ardelyx (ARDX Quick Quote ARDX - Free Report) were up 41% on Nov 17 after management announced thatan FDA Advisory Committee recommended approving the company’s new drug application ...From discovery through commercialization, all of us at Ardelyx ® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first ...Based on the most recent data, ARDX has returned 44.7% so far this year. Meanwhile, the Medical sector has returned an average of 5.3% on a year-to-date basis. This means that Ardelyx is ...According to Seeking Alpha data, Ardelyx's market cap of $864.92M shows decent market confidence, especially with its robust revenue growth forecasts: 2023 at $100.6M, and 2024 at $175.84M ...